Revolution Medicines (RVMD) Interest & Investment Income (2019 - 2026)
Revolution Medicines (RVMD) posted Interest & Investment Income of $35.6 million for Q2 2026, up 1023.89% on a QoQ basis from -$3.9 million in Q1 2026, and up 58.81% year-over-year from $22.4 million in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Interest & Investment Income (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Interest & Investment Income for 8 years, with the latest figure at $35.6 million in Q2 2026.
- On a quarterly basis, Interest & Investment Income rose 58.81% year-over-year to $35.6 million in Q2 2026; TTM through Jun 2026 was $75.1 million, a 16.57% increase from a year earlier, with the FY2025 full-year figure at $90.7 million, up 4.39% from the prior year.
- Interest & Investment Income was $35.6 million for Q2 2026 at Revolution Medicines, up from -$3.9 million in the prior quarter.
- The five-year high for Interest & Investment Income was $35.6 million in Q2 2026, with the low at -$3.9 million in Q1 2026.
- Average Interest & Investment Income over 5 years is $9.3 million, with a median of $2.1 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income plunged 1613.21% in 2022, then surged 3469.02% in 2025.
- Over 5 years, Interest & Investment Income stood at -$1.8 million in 2022, then surged by 1182.54% to $19.0 million in 2023, then increased by 11.85% to $21.2 million in 2024, then advanced by 0.32% to $21.3 million in 2025, then jumped by 67.1% to $35.6 million in 2026.
- The last three Interest & Investment Income figures came in at $35.6 million (Q2 2026), -$3.9 million (Q1 2026), and $21.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 120.60 Mn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | 35.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.58 Mn |
| Mar 31, 2026 | -3.85 Mn |
| Dec 31, 2025 | 21.29 Mn |
| Sep 30, 2025 | 22.08 Mn |
| Jun 30, 2025 | 22.40 Mn |
| Mar 31, 2025 | 386,000.00 |
| Dec 31, 2024 | 21.23 Mn |
| Sep 30, 2024 | 20.41 Mn |
| Jun 30, 2024 | -665,000.00 |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | 18.98 Mn |
| Sep 30, 2023 | 10.95 Mn |
| Jun 30, 2023 | -695,000.00 |
| Mar 31, 2023 | 1.22 Mn |
| Dec 31, 2022 | -1.75 Mn |
| Sep 30, 2022 | 2.91 Mn |
| Jun 30, 2022 | -481,000.00 |
| Mar 31, 2022 | -908,000.00 |
| Dec 31, 2021 | 237,000.00 |
| Sep 30, 2021 | 223,000.00 |
API Access
Revolution Medicines Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();